Global Status Report on Cancer 2026

The Global Status Report on Cancer 2026 was jointly released by the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC). It provides a comprehensive assessment of the global cancer burden, regional trends, healthcare preparedness, access to treatment and policy responses. The report promotes a people-centred approach covering cancer prevention, early detection, treatment, survivorship and palliative care.

Global Cancer Burden

Cancer is an increasingly important global public health and development challenge. Around 20.6 million new cancer cases and nearly 10 million cancer deaths occur every year, making cancer the second leading cause of death globally after cardiovascular diseases. Without stronger prevention, early diagnosis and treatment, annual cancer cases could rise to nearly 35 million by 2050.

Asia accounts for more than half of global cancer cases and deaths, while lung cancer remains the leading cause of cancer deaths globally. Among men, lung, prostate and colorectal cancers are major contributors, while breast, lung and colorectal cancers account for a high proportion of the cancer burden among women.

Inequality in Cancer Care

The report highlights significant global inequalities in cancer prevention and treatment. Fewer than one-third of countries currently provide comprehensive cancer care under Universal Health Coverage (UHC). The availability of the 20 priority cancer medicines is also much lower in low- and lower-middle-income countries than in high-income countries.

There has nevertheless been progress in cancer governance. Around 82% of countries now have National Cancer Control Plans, compared with only 50% in 2010. However, implementation remains constrained by limited finance, inadequate infrastructure and shortages of trained healthcare professionals.

Major Causes of Rising Cancer Cases

Demographic and Lifestyle Factors

The rising cancer burden is driven by population ageing, tobacco and alcohol consumption, unhealthy diets, obesity and physical inactivity. Rapid urbanisation and changing lifestyles have further increased exposure to behavioural risk factors associated with non-communicable diseases.

Infections and Environmental Factors

Infections such as Human Papillomavirus (HPV), Hepatitis B, Hepatitis C and Helicobacter pylori continue to contribute significantly to cancer incidence. Increasing exposure to air pollution and other environmental carcinogens is also adding to the cancer burden.

Importantly, nearly four in ten cancer cases are linked to preventable risk factors, highlighting the importance of stronger preventive healthcare and health-promotion measures.

Impact of the Rising Cancer Burden

The growing cancer burden places increasing pressure on healthcare systems, particularly by increasing demand for diagnostic facilities, oncology specialists, treatment centres and palliative care. High treatment costs and productivity losses can also create serious economic hardship for patients and families.

Cancer also has major social and developmental consequences, including emotional stress, caregiver burden and reduced quality of life. Unequal access to prevention, diagnosis and treatment further widens health inequalities and threatens progress towards Universal Health Coverage and SDG 3 (Good Health and Well-being).

Cancer Burden in India

India is experiencing a steady rise in cancer cases, making cancer one of the country's major public health challenges. India records around 15.6 lakh new cancer cases and nearly 8.7 lakh cancer deaths every year.

Among Indian women, breast cancer is the most common cancer, while oral cancer is the leading cancer among men, largely associated with widespread tobacco use. Other important cancers include lung, cervical, oesophageal, stomach and colorectal cancers.

The North-Eastern States, particularly Mizoram, Nagaland, Meghalaya, Arunachal Pradesh and Assam, record high cancer incidence rates, especially for tobacco-related cancers. A major concern is late diagnosis, with around 60–70% of patients reportedly diagnosed at advanced stages, which reduces survival and increases treatment costs.

Government Initiatives in India

India has adopted a multi-dimensional approach to cancer control, focusing on prevention, early detection, affordable treatment and healthcare infrastructure. The National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) supports screening and early detection, while Tertiary Care Cancer Centres are being expanded to improve access to specialised treatment.

Financial protection is strengthened through Ayushman Bharat–PM-JAY, while affordable medicines are made available through Jan Aushadhi Kendras and AMRIT Pharmacies. The government has also provided customs duty exemptions on several life-saving cancer medicines.

Major Challenges in Cancer Control

Late Diagnosis and Weak Surveillance

Late diagnosis remains a major challenge because of low awareness, inadequate screening and delayed health-seeking behaviour. In addition, inadequate cancer surveillance and gaps in death registration and cause-of-death certification affect accurate estimation of the disease burden.

Unequal Healthcare Access

Specialised doctors, diagnostic facilities and advanced cancer treatment remain concentrated largely in urban centres, creating significant regional disparities in cancer care. High treatment and long-term care costs further increase the financial burden on households.

Infrastructure and Workforce Gaps

Shortages of oncology specialists, cancer centres, diagnostic facilities and essential medicines continue to affect cancer control, particularly in low- and middle-income countries. The rising number of patients is placing additional pressure on healthcare infrastructure, workforce and public health financing.

Key Recommendations

The report emphasises stronger cancer prevention through tobacco and alcohol control, healthy diets, physical activity, HPV and Hepatitis B vaccination, and reduced exposure to environmental and occupational carcinogens.

It recommends expanding cancer screening and early detection, improving diagnostic and pathology services, and integrating comprehensive cancer care into Universal Health Coverage to ensure affordable diagnosis, treatment, palliative care and essential medicines.

Countries should also invest in oncology infrastructure, trained healthcare professionals, cancer surveillance, registries, research and innovation. A people-centred approach should provide financial protection, mental-health and psychosocial support, recognise caregivers and involve cancer survivors in policymaking.